Nikolaus Friedrich Rentschler
Directeur Général chez Dr. Rentschler Holding GmbH & Co. KG
Profil
Nikolaus Friedrich Rentschler is currently the Chairman-Supervisory Board at Rentschler Biopharma SE, Chairman-Supervisory Board & Co-Managing Director at Rentschler Biotechnologie Beteiligungs GmbH, Managing Director at Dr. Rentschler Holding GmbH & Co. KG, Director at Kenta Biotech AG, Managing Director at Rentschler Immobilien GmbH & Co. KG, and Co-Managing Director at Rentschler Beteiligungs GmbH.
Previously, he held positions as Managing Director at Rentschler Biopharma SE, Principal at Rentschler Arzneimittel GmbH, and Principal at Schering GmbH & Co. Produktions KG.
He completed his undergraduate studies at the University of Bayreuth and Ludwig-Maximilians-Universität München in 1998.
Postes actifs de Nikolaus Friedrich Rentschler
| Sociétés | Poste | Début |
|---|---|---|
Kenta Biotech AG
 Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Directeur/Membre du Conseil | - |
Dr. Rentschler Holding GmbH & Co. KG
 Dr. Rentschler Holding GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Dr. Rentschler Holding GmbH & Co. KG operates as a holding company with interests in pharmaceutical research and production. Its services include project management, cell line and process developing, as well as analytics and quality controlling solutions. The company was founded in 1927 and is headquartered in Laupheim, Germany. | Directeur Général | - |
Rentschler Biopharma SE
 Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Rentschler Biopharma SE develops and produces pharmaceutical products. Its solutions include bioprocess development, bio manufacturing, associated consulting activities including cell line process, cell culture, aseptic filling, consulting, planning and project management services. The company was founded in 1927 and is headquartered in Laupheim, Germany. | Président | - |
Rentschler Biotechnologie Beteiligungs GmbH
 Rentschler Biotechnologie Beteiligungs GmbH Financial ConglomeratesFinance Part of Dr. Rentschler Holding GmbH & Co. KG, Rentschler Biotechnologie Beteiligungs GmbH is a German company that provides investment services. The company is based in Laupheim, Germany. The CEOs of the company are Jürgen Müller, Nikolaus Friedrich Rentschler. | Directeur Général | - |
Rentschler Immobilien GmbH & Co. KG
 Rentschler Immobilien GmbH & Co. KG Financial ConglomeratesFinance Rentschler Immobilien GmbH & Co. KG provides investment services. The private company is based in Laupheim, Germany. The CEO of the German company is Nikolaus Friedrich Rentschler. | Directeur Général | - |
Rentschler Beteiligungs GmbH
 Rentschler Beteiligungs GmbH Financial ConglomeratesFinance Rentschler Beteiligungs GmbH is an investment holding German company. The private company is based in Laupheim, Germany. The CEOs are Nikolaus Friedrich Rentschler, Jürgen Müller. The company was founded in 1998. | Directeur Général | - |
Anciens postes connus de Nikolaus Friedrich Rentschler
| Sociétés | Poste | Fin |
|---|---|---|
Schering GmbH & Co. Produktions KG
 Schering GmbH & Co. Produktions KG Pharmaceuticals: MajorHealth Technology Schering GmbH & Co. Produktions KG manufactures medicines for treating disorders of the menstrual cycle. The company's product Primolut N contains norethisterone which is a progestogen (a female hormone) used to treat irregular, painful or heavy periods. It is also used in the treatment of endometriosis (presence of tissue from the lining of the womb in places where it is not normally found). Schering GmbH was founded in 1851 and is headquartered in Weimar, Germany. | Corporate Officer/Principal | - |
Rentschler Biopharma SE
Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Rentschler Biopharma SE develops and produces pharmaceutical products. Its solutions include bioprocess development, bio manufacturing, associated consulting activities including cell line process, cell culture, aseptic filling, consulting, planning and project management services. The company was founded in 1927 and is headquartered in Laupheim, Germany. | President | - |
Rentschler Arzneimittel GmbH
 Rentschler Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Part of MEDICE Arzneimittel Pütter GmbH & Co. KG, Rentschler Arzneimittel GmbH is a German company that manufactures over-the-counter drugs. The company is based in Laupheim, Germany. Rentschler Arzneimittel was acquired by MEDICE Arzneimittel Pütter GmbH & Co. KG from Dr. Rentschler Holding GmbH & Co. KG on March 16, 2006. | Corporate Officer/Principal | - |
Formation de Nikolaus Friedrich Rentschler
| University of Bayreuth | Undergraduate Degree |
| Ludwig-Maximilians-Universität München | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Rentschler Arzneimittel GmbH
Rentschler Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Part of MEDICE Arzneimittel Pütter GmbH & Co. KG, Rentschler Arzneimittel GmbH is a German company that manufactures over-the-counter drugs. The company is based in Laupheim, Germany. Rentschler Arzneimittel was acquired by MEDICE Arzneimittel Pütter GmbH & Co. KG from Dr. Rentschler Holding GmbH & Co. KG on March 16, 2006. | Health Technology |
Schering GmbH & Co. Produktions KG
Schering GmbH & Co. Produktions KG Pharmaceuticals: MajorHealth Technology Schering GmbH & Co. Produktions KG manufactures medicines for treating disorders of the menstrual cycle. The company's product Primolut N contains norethisterone which is a progestogen (a female hormone) used to treat irregular, painful or heavy periods. It is also used in the treatment of endometriosis (presence of tissue from the lining of the womb in places where it is not normally found). Schering GmbH was founded in 1851 and is headquartered in Weimar, Germany. | Health Technology |
Rentschler Biopharma SE
Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Rentschler Biopharma SE develops and produces pharmaceutical products. Its solutions include bioprocess development, bio manufacturing, associated consulting activities including cell line process, cell culture, aseptic filling, consulting, planning and project management services. The company was founded in 1927 and is headquartered in Laupheim, Germany. | Health Technology |
Dr. Rentschler Holding GmbH & Co. KG
Dr. Rentschler Holding GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Dr. Rentschler Holding GmbH & Co. KG operates as a holding company with interests in pharmaceutical research and production. Its services include project management, cell line and process developing, as well as analytics and quality controlling solutions. The company was founded in 1927 and is headquartered in Laupheim, Germany. | Commercial Services |
Rentschler Immobilien GmbH & Co. KG
Rentschler Immobilien GmbH & Co. KG Financial ConglomeratesFinance Rentschler Immobilien GmbH & Co. KG provides investment services. The private company is based in Laupheim, Germany. The CEO of the German company is Nikolaus Friedrich Rentschler. | Finance |
Rentschler Biotechnologie Beteiligungs GmbH
Rentschler Biotechnologie Beteiligungs GmbH Financial ConglomeratesFinance Part of Dr. Rentschler Holding GmbH & Co. KG, Rentschler Biotechnologie Beteiligungs GmbH is a German company that provides investment services. The company is based in Laupheim, Germany. The CEOs of the company are Jürgen Müller, Nikolaus Friedrich Rentschler. | Finance |
Rentschler Beteiligungs GmbH
Rentschler Beteiligungs GmbH Financial ConglomeratesFinance Rentschler Beteiligungs GmbH is an investment holding German company. The private company is based in Laupheim, Germany. The CEOs are Nikolaus Friedrich Rentschler, Jürgen Müller. The company was founded in 1998. | Finance |
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Health Technology |